REAGENT or RESOURCE | SOURCE | IDENTIFIER |
---|---|---|
Bacterial and virus strains | ||
SARS-CoV-2/Hu/DP/Kng/19-020 | Kanagawa Prefectural Institute of Public Health | N/A |
Escherichia coli DH5-α | New England Biolabs | Cat#C2987 |
Chemicals, peptides, and recombinant proteins | ||
100 unit/ml penicillin and 100 μg/ml streptomycin (P/S) | Sigma | Cat#09367-34 |
G418 | Nacalai Tesque | Cat#09380-44 |
Blasticidin solution | InvivoGen | Cat#ant-bl |
Doxycycline hydrochloride | Sigma | Cat#D3447-500MG |
Trans IT LT-1 | Mirus | Cat#MIR2306 |
PureLink RNA Mini Kit | Thermo Fisher Scientific | Cat#12183025 |
PrimeScript RT reagent kit (Perfect Real Time) | TaKaRa Bio | Cat#RR037A-3 |
PrimeSTAR GXL DNA polymerase | TaKaRa Bio | Cat#R050A |
5′RACE System for Rapid Amplification of cDNA Ends, Version 2.0 | Thermo Fisher Scientific | Cat#18374-041 |
DIG RNA Labeling kit (SP6/T7) | Roche | Cat#1175025910 |
DIG wash and block buffer set | Roche | Cat#11585762001 |
CDP-Star Chemiluminescent substrate | Sigma | Cat#c0721-100ml |
Nano-Glo HiBiT Lytic detection system | Promega | Cat#N3030 |
Experimental models: Cell lines | ||
Vero E6 cells | American Type Culture Collection | CRL-1586 |
BHK-21 cells | Japanese Collection of Research Bioresources Cell Bank | JCRB9020 |
TMPRSS2-expressing Vero E6 cells | Japanese Collection of Research Bioresources Cell Bank | JCRB1819 |
Tetracycline-inducible ACE2 and TMPRSS-expressing IFNAR1-deficient HEK293 (HEK293-3P6C33) cells | This paper | N/A |
Oligonucleotides | ||
CoV-2-G1-Fw (attaaaggtttataccttcccaggtaa caaaccaaccaactttcgatctc) |
Fasmac | N/A |
CoV-2-G1-Rv (tctacacaaactcttaa agaatgtataggg) |
Fasmac | N/A |
CoV-2-G2-Fw (cggcagtgaggacaatcagacaactac) | Fasmac | N/A |
CoV-2-G2-Rv (ggcttagcataattagctatagtatcccaagggac) | Fasmac | N/A |
CoV-2-G3-Fw (gccacgtataaaccaaatacctggtgtatacg) | Fasmac | N/A |
CoV-2-G3-Rv (ggtgcacagcgcagcttcttcaaaagtactaaagg) | Fasmac | N/A |
CoV-2-G4-Fw (agtggtagatgggtacttaacaatgattattac) | Fasmac | N/A |
CoV-2-G4-Rv (gtttaaaaacgattgtgcatcagctgactg) | Fasmac | N/A |
CoV-2-G5-Fw (acaacctaaatagaggtatggtacttggtag) | Fasmac | N/A |
CoV-2-G5-Rv (gtggtttatgtgatttacaataatagctc) | Fasmac | N/A |
CoV-2-G6-Fw (tgtagatgatatcgtaaaaacagatggtacac) | Fasmac | N/A |
CoV-2-G6-Rv (aacgtgttatacacgtagcagactttagtggtac) | Fasmac | N/A |
CoV-2-G7-Fw (aaaggttcaacacatggttgttaaagctgc) | Fasmac | N/A |
CoV-2-G7-Rv (cgtacactttgtttctgagagagggtc) | Fasmac | N/A |
CoV-2-G8-Fw (atgtttgtttttcttgttttattgccactag) | Fasmac | N/A |
CoV-2-G8-Rv (aagttcgtttatgtgtaatgtaatttgactcc) | Fasmac | N/A |
CoV-2-G9-Fw (gaaccacaaatcattactacagacaacac) | Fasmac | N/A |
CoV-2-G9-Rv (gttcgtttaggcgtgacaagtttcattatg) | Fasmac | N/A |
CoV-2-G10-Fw (atgtttcatctcgttgactttcaggttactatag) | Fasmac | N/A |
CoV-2-G10-Rv (tttttttttttttttttttttttttgtcattctcc) | Fasmac | N/A |
CoV-2-Race1 (gctgatgatcggctgcaacacggacg) | Fasmac | N/A |
CoV-2-Race2 (gccacacagattttaaagttcgtttagag) | Fasmac | N/A |
CoV-2-F1-Fw (CTATATAAGCAGAGCTCGTTTAGTGA ACCGTattaaaggtttataccttcccaggtaac) |
Fasmac | N/A |
CoV-2-F1-Rv (cagattcaacttgcatggcattgttagtagccttatttaaggctcctgc) | Fasmac | N/A |
CoV-2-F2-Fw (gcaggagccttaaataaggctactaacaatgccatgcaagttgaatctg) | Fasmac | N/A |
CoV-2-F2-Rv (ggtaggattttccactacttcttcagagactggttttagatcttcgcaggc) | Fasmac | N/A |
CoV-2-F3-Fw (gcctgcgaagatctaaaaccagtctctgaagaagtagtggaaaatcctacc) | Fasmac | N/A |
CoV-2-F3-Rv (ggtgcacagcgcagcttcttcaaaagtactaaagg) | Fasmac | N/A |
CoV-2-F4-Fw (caccactaattcaacctattggtgctttggacatatcagcatctatagtagctggtgg) | Fasmac | N/A |
CoV-2-F4-Rv (gtttaaaaacgattgtgcatcagctgactg) | Fasmac | N/A |
CoV-2-F5-Fw (cacagtctgtaccgtctgcggtatgtggaaaggttatggctgtagttgtgatc) | Fasmac | N/A |
CoV-2-F5-Rv (gcggtgtgtacatagcctcataaaactcaggttcccaataccttgaagtg) | Fasmac | N/A |
CoV-2-F6-Fw (cacttcaaggtattgggaacctgagttttatgaggctatgtacacaccgc) | Fasmac | N/A |
CoV-2-F6-Rv (catacaaactgccaccatcacaaccaggcaagttaaggttagatagcactctag) | Fasmac | N/A |
CoV-2-F7-Fw (ctagagtgctatctaaccttaacttgcctggttgtgatggtggcagtttgtatg) | Fasmac | N/A |
CoV-2-F7-Rv (ctagagactagtggcaataaaacaagaaaaacaaacattgttcgtttagttgttaac) | Fasmac | N/A |
CoV-2-F8-Fw (gttaacaactaaacgaacaatgtttgtttttcttgttttattgccactagtctctag) | Fasmac | N/A |
CoV-2-F8-Rv (gcagcaggatccacaagaacaacagcccttgagacaactacagcaactgg) | Fasmac | N/A |
CoV-2-F9-Fw (ccagttgctgtagttgtctcaagggctgttgttcttgtggatcctgctgc) | Fasmac | N/A |
CoV-2-F9-Rv (caatctccattggttgctcttcatc) | Fasmac | N/A |
CoV-2-F10-Fw (gatgaagagcaaccaatggagattg) | Fasmac | N/A |
CoV-2-F10-Rv (GGAGATGCCATGCCGACC Ctttttttttttttttttttttttttgtcattctcctaag) |
Fasmac | N/A |
CoV-2-Linker-Fw (cttaggagaatgacaaaaaaaaaaaa aaaaaaaaaaaaaGGGTCGGCATGGCATCTCC) |
Fasmac | N/A |
CoV-2-Linker-Rv (gttacctgggaaggtataaacctttaatA CGGTTCACTAAACGAGCTCTGCTTATATAG) |
Fasmac | N/A |
ORF6-HiBiT-Rv (ccGCTAATCTTCTTGAACAGCCGCCAGCCGCTCA Ccatctgttgtcacttactgtacaagcaaagcaatattgtcactgc) |
Fasmac | N/A |
ORF6-HiBiT-Fw (CTGTTCAAGAAGATTAGCgggagttctggctttcatct cgttgactttcaggttactatagcagagatattactaattat) |
Fasmac | N/A |
Recombinant DNA | ||
pCSII-CoV-2-G1 | This paper | N/A |
pCSII-CoV-2-G2 | This paper | N/A |
pCSII-CoV-2-G3 | This paper | N/A |
pCSII-CoV-2-G4 | This paper | N/A |
pMW-CoV-2-G5 | This paper | N/A |
pMW-CoV-2-G6 | This paper | N/A |
pCSII-CoV-2-G7 | This paper | N/A |
pCSII-CoV-2-G8 | This paper | N/A |
pCSII-CoV-2-G9 | This paper | N/A |
pCSII-CoV-2-G10 | This paper | N/A |
pMW-CoV-2-UTRlinker | This paper | N/A |
pCSII-CoV-2-G10-sfGFP | This paper | N/A |
pCAGGS-CoV-2-N | This paper | N/A |